These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32065902)

  • 21. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy.
    Habr-Gama A; São Julião GP; Vailati BB; Sabbaga J; Aguilar PB; Fernandez LM; Araújo SEA; Perez RO
    Ann Surg; 2019 Jan; 269(1):102-107. PubMed ID: 28742703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do t3 rectal cancers always need radiochemotherapy?
    Glynne-Jones R
    Recent Results Cancer Res; 2014; 203():95-115. PubMed ID: 25103002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of tumor distance from anal verge and types of operations on survival outcomes for low rectal cancer after neoadjuvant chemoradiotherapy].
    Xiao Y; Wu B; Qiu H; Xiong G; Lin G; Zhong G; Hu K; Pan W
    Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(22):1705-9. PubMed ID: 25151899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
    Crane CH; Skibber JM; Feig BW; Vauthey JN; Thames HD; Curley SA; Rodriguez-Bigas MA; Wolff RA; Ellis LM; Delclos ME; Lin EH; Janjan NA
    Cancer; 2003 Jan; 97(2):517-24. PubMed ID: 12518377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
    Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients?
    Park IJ; Yu CS; Lim SB; Lee JL; Kim CW; Yoon YS; Park SH; Kim JC
    Medicine (Baltimore); 2016 May; 95(18):e3463. PubMed ID: 27149445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
    J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
    Blazic IM; Lilic GB; Gajic MM
    Radiology; 2017 Feb; 282(2):418-428. PubMed ID: 27253423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.
    Bates DDB; Golia Pernicka JS; Fuqua JL; Paroder V; Petkovska I; Zheng J; Capanu M; Schilsky J; Gollub MJ
    Abdom Radiol (NY); 2020 Feb; 45(2):293-300. PubMed ID: 31690966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
    Wang X; Chen G; Zhang Y; Ghareeb WM; Yu Q; Zhu H; Lu X; Huang Y; Huang S; Hou D; Chi P
    Eur J Surg Oncol; 2020 Jun; 46(6):1118-1123. PubMed ID: 32113887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
    Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
    Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
    Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
    Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
    Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical parameters predictive for sphincter-preserving surgery and prognostic outcome in patients with locally advanced low rectal cancer.
    Partl R; Magyar M; Hassler E; Langsenlehner T; Kapp KS
    Radiat Oncol; 2020 May; 15(1):99. PubMed ID: 32375894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.
    Hu JJ; Liang JW; Wang Z; Zhang XM; Zhou HT; Hou HR; Zhou ZX
    J Surg Res; 2014 Apr; 187(2):438-44. PubMed ID: 24252856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
    Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
    J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.